Table 2.
Bimatoprost Group | Control Group | Mean Difference± SD | P-value* | |||||
---|---|---|---|---|---|---|---|---|
N | Changes (mean±SD) | P-value | N | Changes (mean±SD) | P-value | |||
Changes from Baseline to Cessation of Gel Application (6 weeks) | 15 | 2.0±1.5 | <0.001 | 15 | 1.1±1.1 | 0.001 | 0.9 ± 1.1 | 0.009 |
Changes from Baseline to 1 month after Cessation | 13 | 1.9±1.3 | <0.001 | 13 | 1.0±1.1 | 0.009 | 0.9 ± 1.2 | 0.013 |
Changes from Baseline to 3 Month after Cessation | 15 | 1.9±1.2 | <0.001 | 15 | 0.8±1.2 | 0.017 | 1.1 ± 0.7 | <0.001 |
Changes from Cessation of Gel Application to 3 Months after Cessation | 15 | −0.1±0.6 | 0.58 | 15 | −0.3±0.7 | 0.09 | 0.2 ± 1.0 | 0.39 |
Paired t-test.
SD = Standard Deviation